| Dr Mohammed S Dhamee, MD | |
|
9200 W Wisconsin Ave, Hospital Based @ Froedtert Hosp., Milwaukee, WI 53226-3522 | |
| (414) 805-3666 | |
| Not Available |
| Full Name | Dr Mohammed S Dhamee |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 9200 W Wisconsin Ave, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013968197 | NPI | - | NPPES |
| 30152700 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 20459 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mohammed S Dhamee, MD 9200 W Wisconsin Ave, Hospital Based @ Froedtert Hosp., Milwaukee, WI 53226-3522 Ph: () - | Dr Mohammed S Dhamee, MD 9200 W Wisconsin Ave, Hospital Based @ Froedtert Hosp., Milwaukee, WI 53226-3522 Ph: (414) 805-3666 |
News Archive
TessArae, LLC, a privately held company, and Affymetrix Inc., (NASDAQ:AFFX) today announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to TessArae for its TessArray® Resequencing Influenza A Microarray Detection Panel for the Detection of the 2009 H1N1 Influenza A Virus (TessArray RM-Flu test) for the duration of the declaration of emergency unless revoked earlier. The declaration of emergency will expire on April 26, 2010, unless terminated earlier or renewed.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced results from a preclinical study of a selective histone deacetylase (HDAC) 1/2 inhibitor for the treatment of sickle cell disease (SCD) and beta-thalassemia (bT) at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place in Atlanta, Georgia.
NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, reports that it is accelerating its HerpeCide drug development program.
Aradigm Corporation (the "Company") today announced that the U.S. Food and Drug Administration (FDA) has designated the Company's lead inhaled antibiotic candidate, Pulmaquin®, as a Qualified Infectious Disease Product (QIDP).
› Verified 5 days ago
Dr. Jeffrey T Lyvers, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2900 W Oklahoma Ave, Milwaukee, WI 53215 Phone: 414-649-6000 | |
Dr. Nosheen Hasan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7235 W Appleton Ave, Sutie 102, Milwaukee, WI 53216 Phone: 414-444-8670 Fax: 414-444-8678 | |
Dr. Quinn Hogan, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Department Of Anesthesiology, Milwaukee, WI 53226 Phone: 414-805-8700 Fax: 414-259-1522 | |
Dr. Stephen R Thompson, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2025 E Newport Ave, Milwaukee, WI 53211 Phone: 414-961-3300 | |
Dr. Christina D Diaz, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Department Of Anesthesiology, Milwaukee, WI 53226 Phone: 414-805-8700 Fax: 414-259-1522 | |
Dr. John V Selthafner, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-8700 Fax: 414-259-1522 | |
Anne M Fagan, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 10200 W Innovation Dr, Milwaukee, WI 53226 Phone: 414-302-9196 |